Sanofi (SNY) wins U.S. FDA approval for Aubagio, a pill designed to treat multiple sclerosis,...

|About: Sanofi (SNY)|By:, SA News Editor

Sanofi (SNY) wins U.S. FDA approval for Aubagio, a pill designed to treat multiple sclerosis, making it the second oral therapy that will be available on the U.S. market. The drug will compete with Novartis' (NVS) Gilenya, an oral pill which was approved by the FDA in 2010.